Drug persistence is similar with rivastigmine and donepezil in Alzheimer's disease patients

被引：0
|
作者：
Mauskopf, J
Paramore, C
Lee, WC
McBurney, CR
Snyder, EH
机构：
[1] Res Triangle Inst, Chapel Hill, NC USA
[2] MEDTAP Int, Bethesda, MD USA
[3] Abt Associates Inc, Bethesda, MD USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80685-7
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S204 / S204
页数：1
相关论文
共 50 条
  • [31] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline
    Evans, John Grimley
    Iakovidou, Vasso
    Tsolaki, Magda
    Holt, Francesca E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):
  • [32] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline S.
    Evans, John Grimley
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [33] Rivastigmine patch and massage for Alzheimer's disease patients
    Satoh, Sachiko
    Kajiwara, Mutsuko
    Kiyokawa, Emi
    Toukairin, Yoshiko
    Fujii, Masahiko
    Sasaki, Hidetada
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2013, 13 (02) : 515 - 516
  • [34] Rivastigmine in patients with Alzheimer's disease and concurrent hypertension
    Erkinjuntti, T
    Skoog, I
    Lane, R
    Andrews, C
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (10) : 791 - 796
  • [35] Results of next day crossover study of donepezil to rivastigmine in Alzheimer's disease patients: A one month prospective study
    Amin, S
    Shua-Haim, J
    Smith, J
    GERONTOLOGIST, 2002, 42 : 206 - 206
  • [36] The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease
    Kazmierski, Jakub
    Messini-Zachou, Chaido
    Gkioka, Mara
    Tsolaki, Magda
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2018, 33 (06): : 385 - 393
  • [37] Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease - A systematic review
    Clegg, A
    Bryant, J
    Nicholson, T
    McIntyre, L
    De Broe, S
    Gerard, K
    Waugh, N
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (03) : 497 - 507
  • [38] COST-EFFECTIVENESS ANALYSIS OF DONEPEZIL AND RIVASTIGMINE FOR MILD TO MODERATE ALZHEIMER'S DISEASE IN TAIWAN
    Chen, T. S.
    Lang, H. C.
    VALUE IN HEALTH, 2013, 16 (03) : A104 - A104
  • [39] Rivastigmine: An acetylcholinesterase inhibitor for patients with Alzheimer's disease
    White, CM
    Dicks, RS
    FORMULARY, 1999, 34 (06) : 493 - +
  • [40] SWAP: Safety and tolerability of switching oral donepezil to rivastigmine patch in Alzheimer's disease (AD)
    Alva, Gustavo
    Farlow, Martin
    Sadowsky, Carl
    Brannan, Stephen
    ANNALS OF NEUROLOGY, 2008, 64 : S39 - S40
12345